This translation has been automatically generated and has not been verified for accuracy.A U.S. bankruptcy judge on Thursday urged parties that will benefit from a proposed settlement with OxyContin maker Purdue Pharma LP to focus on addressing the opioid addiction crisis and avoid battling over the deal’s billions of dollars.
The deal aims to resolve more than 2,600 lawsuits by states, local governments and other plaintiffs against Purdue and its Sackler family owners. The lawsuits accuse them of fueling a public health crisis by aggressively marketing opioids while downplaying their overdose risks, contributing to 400,000 deaths since 1999, according to U.S. statistics.“No one can ignore the individual people affected by this crisis,” said U.S. Bankruptcy Judge Robert Drain at a Thursday hearing.
He mentioned as examples the litigation settlements involving victims of Vietnam War herbicide Agent Orange, the Sept. 11, 2001 attacks and the BP Plc oil spill. Those cases were resolved using compensation funds established to settle large numbers of lawsuits for personal injury and other claims. Drain also said bankruptcy law could be used to bind permanently how the Purdue settlement funds were used.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CTVNews - 🏆 1. / 99 Read more »
Source: nationalpost - 🏆 10. / 80 Read more »
Source: globeandmail - 🏆 5. / 92 Read more »
Source: globeandmail - 🏆 5. / 92 Read more »